Hólyagrák: vizsgálatok itt: Brazília
11 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- Where
- Barretos, Campinas, Natal, Porto Alegre, Salvador, Santo André, São Paulo
- Életkor
- 18 év and over
- People
- 641 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06319820 - 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Where
- Natal, Presidente Prudente, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06919965 · EU 2024-519493-39-00 - 3. fázisTaking peopleA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Where
- Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07419295 · EU 2024-520014-22-00 - No phaseNot yet taking people in BrazíliaRadical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
- Where
- São Paulo
- Életkor
- 18 év to 80 év
- People
- 336
- Run by
- Brazilian Clinical Research Institute
See details and how to joinNCT07008833 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barretos, Florianópolis, Jaú, Porto Alegre
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2. fázisTaking peoplePerioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
- Where
- Barretos, Jaú, Natal, Porto Alegre, Rio de Janeiro, Santo André, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06960577 · EU 2024-519246-75-01 - 3. fázisTaking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Barretos, Belém, Bento Gonçalves, Curitiba, Londrina, Natal, Porto Alegre, Santa Cruz do Sul, São Caetano do Sul, São Paulo
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Barretos, Curitiba, Passo Fundo, São Jose Do Rio Preto
- Életkor
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - 2. fázisTaking peopleSafety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Where
- Campinas, Jardim Paulista, Nova Lima, Porto Alegre, Santo André
- Életkor
- 18 év and over
- People
- 131 worldwide
- Run by
- Protara Therapeutics
See details and how to joinNCT05951179 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Porto Alegre, Rio de Janeiro, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762 - 3. fázisTaking peopleAn Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Where
- Barretos, Curitiba, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 915 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07720284